Dr. Robert Leland Baker, MD

Dr. Baker practices at Wallace C Baker in Covina, California.

Dr. Baker's NPI, 1033107750, was assigned on October 6, 2005. Dr. Baker graduated from Keck School of Medicine of USC in 1985. Dr. Baker's California license number on file is G58468.

Dr. Baker's primary practice is Wallace C Baker, at 250 W Badillo St, Covina, CA 91723 in Los Angeles County. The practice phone is (208) 524-6633.

Dr. Baker's primary practice is Wallace C Baker in Covina, California. Dr. Baker is also affiliated with Emanate Health Inter-Community Hospital. Dmand AI also links Dr. Baker to 3 more hospitals, 4 home health agencies and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Baker practices, 9 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. Baker's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dr. Baker is board certified in family medicine by the American Board of Family Medicine. Dr. Baker has a license on file in California.

Dmand AI lists acid reflux, acne, acute mini-stroke (TIA), acute sinusitis, acute skin infection, adjustment disease, alzheimer's disease and aneurysm among the conditions Dr. Baker treats.

CMS data shows 28,094 Medicare services from Dr. Baker across 36 procedure codes in 2024, for 693 Medicare patients. Medicare paid $224,702 for them. Every service was in an office.

CMS counts 693 Medicare patients who saw Dr. Baker in 2024. The largest group is 65 to 74, with 308 patients. 69% of them have high blood pressure, and 64% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.06, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Baker's median patient age at 65, with 52% women.

In 2024, Dr. Baker wrote 17,701 Medicare Part D claims for 1,066 patients. 90% of them were for generic drugs. CMS names the drug for 16,838 of them, across 212 drugs with 11 or more claims each, at $1,096,720 in total drug cost. In 2023, CMS named 16,177 claims across 211 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Baker for performance year 2024, reported as part of a group. Dr. Baker accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 103 procedures of removal of skin lesions by Dr. Baker, more than 75% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 35 general payments to Dr. Baker from 17 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $119.

Dr. Baker graduated from Keck School of Medicine of USC in 1985.

Dr. Baker is in network with 14 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.